President was granted access to REGN-COV2 following a compassionate-use request

Market Beat: With M&A activity busy, competition authorities need to be on their toes

Speculative development follows 250,000sq ft of letting activity within the past 12 months

World round-up: China reports new infections as Greece announces record daily number of cases

€63m contract covers 30,000 patients with severe Covid-19 symptoms in Europe

Dublin closes higher as banks bounce back and CRH, Ryanair and Dalata all gain

Company to invest €7m as it also establishes paediatric centre of excellence here

The world would be a worse place without globalisation, says the 58-year-old German

Alert comes after US secures Covid-19 drug treatment for next three months

UN agency ends treatment after results show little or no reduction in mortality

Scale of scientific endeavour is unprecedented with more than 145 candidates in development

Fears of shortages after maker of remdesivir pledges most output to US for next three months

Immunologist says US may struggle to achieve herd immunity even if a vaccine is developed due to prevailing scepticism

EMA committee recommends drug’s use in adults and adolescents from 12 years of age

Warning as Texas, Florida and Arizona all report biggest one-day increases in cases

Shares dip as it emerges there are no active talks on what would be politically sensitive deal

Approval would allow sale of drug in bloc for one year before all data on effects known

On a potential vaccine: ‘the air is thick with absurd promissory notes and dates of delivery’

Stocks soar on promising news remdesivir an effective treatment for virus

Drugs company has about 50,000 courses of remdesivir ready to distribute in the US

Contraction in GDP between January and March exceeded most analysts’ expectations

Governors slam Senate leader McConnell over ‘irresponsible’ state bankruptcy comments

Disappointing results revealed in draft documents published accidentally by WHO

Iseq outperforms European peers and rises 3.83%, with Flutter a standout performer

US shares rise after leaked report enthused about benefits of remdesivir in 125 Covid-19 patients

Early impressions from US study show severely ill patients in clinical trial recovering quickly

Edition 5: Why has virus spread in Ireland been discernibly different to the UK?

Right now, remdesivir is the most promising one in tackling the virus head-on

Scientists are focusing on three main drug types

Here amid the gloom are some positive developments. However, there are caveats

Markets report: Iseq was virtually flat on the day with Ryanair amongst losers

Pharmaceutical company Gilead is working on a drug that is in human trial stage

Netflix’s dystopian dating show asks if it’s what’s inside that really counts (Spoiler: it isn’t)

Iput secures initial rent of €1.6m per annum on 20-year lease of former Eason warehouse

ViiV Healthcare Company and Shionogi & Co are suing Gilead and its Irish subsidiary

South Dublin proving to be an increasingly attractive alternative for global tech giants

The General Synod and not Gafcon decides the policy and doctrine of the Church of Ireland

Book review: Ho Sok Fong has written an inventive, troubling second collection

Lawsuit claims drugmaker reaped billions of dollars through taxpayer-funded research

Booker Prize winning author puts hope in young people in battle against totalitarianism